AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8657506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rHuEPO or iron)
Number of subjects: 19
Study 2261043 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-minute lecture on the value of the autopsy
Number of subjects: 53
Study 2261043 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lecture)
Number of subjects: 53
Study 2261043 — intervention group
Group type: EXPERIMENTAL
Intervention: Total group of housestaff
Number of subjects: 53
Study 6994982 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (1 mg/kg for 3 weeks)
Number of subjects: 22
Study 31609489 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-shaped inter-dental brushes
Number of subjects: 20
Study 31609489 — intervention group
Group type: COMPARATOR
Intervention: Cylindric inter-dental brushes
Number of subjects: 20
Study 31778439 — intervention group
Group type: COMPARATOR
Intervention: Functional electrical stimulation of lower limb muscles (FES group)
Number of subjects: 1084
Study 31778439 — intervention group
Group type: COMPARATOR
Intervention: Tai Chi exercise (TCE group)
Number of subjects: 1084
Study 31778439 — intervention group
Group type: COMPARATOR
Intervention: Functional electrical stimulation of lower limb muscles and Tai Chi exercise (FES & TCE group)
Number of subjects: 1084
Study 28100342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary administration of 6 mg nicorandil after guide wire or balloon successfully crossed the target lesion (n=53)
Number of subjects: 158
Study 28100342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary administration of 300 μg nitroglycerin after guide wire or balloon successfully crossed the target lesion (n=52)
Number of subjects: 158
Study 28100342 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group, n=53)
Number of subjects: 158
Study 25880933 — intervention group
Group type: EXPERIMENTAL
Intervention: SMT19969 (up to 2,000 mg single oral doses)
Number of subjects: 56
Study 25880933 — intervention group
Group type: EXPERIMENTAL
Intervention: SMT19969 (200 mg BID for 10 days)
Number of subjects: 56
Study 25880933 — intervention group
Group type: EXPERIMENTAL
Intervention: SMT19969 (single and multiple oral doses)
Number of subjects: 56
Study 25880933 — intervention group
Group type: EXPERIMENTAL
Intervention: SMT19969 (multiple doses)
Number of subjects: 56
Study 24020707 — intervention group
Group type: EXPERIMENTAL
Intervention: dexmedetomidine-propofol
Number of subjects: 76
Study 24020707 — intervention group
Group type: EXPERIMENTAL
Intervention: dexmedetomidine-thiopenthal
Number of subjects: 76
Study 24020707 — intervention group
Group type: EXPERIMENTAL
Intervention: dexmedetomidine-etomidate
Number of subjects: 76
Study 21214361 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost (BIM) 0.03%
Number of subjects: 33
Study 21214361 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost/timolol fixed combination (BTFC) 0.03%/0.5%
Number of subjects: 33
Study 19726292 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation of ziprasidone (40 mg)
Number of subjects: 20
Study 19726292 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation of ziprasidone (40 mg)
Number of subjects: 20
Study 19726292 — intervention group
Group type: EXPERIMENTAL
Intervention: Both test and reference preparations of ziprasidone
Number of subjects: 20
Study 17846399 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride, 150 mg twice a day
Number of subjects: 593
Study 17846399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593
Study 15500895 — intervention group
Group type: EXPERIMENTAL
Intervention: Regularly scheduled albuterol treatment
Number of subjects: 78
Study 15500895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 15500895 — intervention group
Group type: COMPARATOR
Intervention: Comparison of albuterol vs placebo
Number of subjects: 78
Study 11686808 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical therapy (SU)
Number of subjects: 64
Study 11686808 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical scaling and root planing (SRP)
Number of subjects: 64
Study 9573448 — intervention group
Group type: EXPERIMENTAL
Intervention: Test lunch 1 (1200 kcal, 38% carbohydrate, 50% fat, 12% protein)
Number of subjects: 12
Study 9573448 — intervention group
Group type: EXPERIMENTAL
Intervention: Test lunch 2 (1200 kcal, 38% carbohydrate, 50% fat, 12% protein)
Number of subjects: 12
Study 9573448 — intervention group
Group type: COMPARATOR
Intervention: Both meals
Number of subjects: 12
Study 7934734 — intervention group
Group type: EXPERIMENTAL
Intervention: Antinicotinic therapeutic films containing anabasinum, cytisinum, or their combination in equal ratios applied to the gingiva beneath the upper lip.
Number of subjects: 74
Study 7934734 — intervention group
Group type: EXPERIMENTAL
Intervention: Antinicotinic therapeutic films containing cytisinum and anabasinum in combination or cytisinum alone.
Number of subjects: 74
Study 7934734 — intervention group
Group type: EXPERIMENTAL
Intervention: Antinicotinic therapeutic films.
Number of subjects: 74
Study 3602023 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially-available bowel evacuant kit (magnesium citrate oral solution, phenolphthalein tablets, bisacodyl suppository)
Number of subjects: 195
Study 3602023 — intervention group
Group type: COMPARATOR
Intervention: Castor oil with enemas
Number of subjects: 195
Study 29607595 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up nursing intervention
Number of subjects: 43
Study 29607595 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 43
Study 28825891 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (cholesterol-lowering agent) treatment for 6 months
Number of subjects: 24
Study 28825891 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 24
Study 25545594 — intervention group
Group type: EXPERIMENTAL
Intervention: Late post-pandemic period
Number of subjects: 172
Study 25545594 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who died
Number of subjects: 172
Study 23907204 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT + TMZ 75 mg/m² for 2 weeks followed by TMZ 100 mg/m²/day 2 weeks on/2 weeks off for up to 6 months (RCT)
Number of subjects: 35
Study 23907204 — intervention group
Group type: COMPARATOR
Intervention: WBRT alone (RT)
Number of subjects: 35
Study 21079746 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) and betaine with pegIFNα2b and ribavirin
Number of subjects: 29
Study 21079746 — intervention group
Group type: COMPARATOR
Intervention: pegIFNα/ribavirin
Number of subjects: 29
Study 17892457 — intervention group
Group type: EXPERIMENTAL
Intervention: Loupes-assisted nerve-sparing radical hysterectomy (NSRH)
Number of subjects: 18
Study 17892457 — intervention group
Group type: COMPARATOR
Intervention: Conventional radical hysterectomy type II (RH type II)
Number of subjects: 18
Study 17892457 — intervention group
Group type: COMPARATOR
Intervention: Conventional radical hysterectomy type III (RH type III)
Number of subjects: 18
Study 15725986 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal group (BMD testing offered to all); 1986 contacted, 415 participated
Number of subjects: 4167
Study 15725986 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORE group (BMD testing for women scoring >= 7 on SCORE questionnaire); 1940 contacted, 576 participated
Number of subjects: 4167
Study 15725986 — intervention group
Group type: COMPARATOR
Intervention: SOF-based group (BMD testing for women with >= 5 hip fracture risk factors); 5342 contacted, 2176 participated
Number of subjects: 4167
Study 15725986 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal group
Number of subjects: 4167
Study 15725986 — intervention group
Group type: COMPARATOR
Intervention: SOF-based group
Number of subjects: 4167
Study 12555300 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 205
Study 12555300 — intervention group
Group type: COMPARATOR
Intervention: Diathermy haemorrhoidectomy
Number of subjects: 205
Study 12555300 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 205
Study 10376694 — intervention group
Group type: EXPERIMENTAL
Intervention: Single treatment (9 subjects)
Number of subjects: 67
Study 10376694 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple treatments (58 subjects)
Number of subjects: 67
Study 10376694 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 67
Study 8905942 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine tape (Penles) applied 30-60 min before epidural block (groups 1 and 2)
Number of subjects: 96
Study 8905942 — intervention group
Group type: COMPARATOR
Intervention: Eutectic mixture of lidocaine and tetracaine (LT ointment) applied 1-2 h before block (group 3)
Number of subjects: 96
Study 8905942 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 5 mg intramuscularly (groups 2 and 3)
Number of subjects: 96
Study 1867967 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam 15 mg
Number of subjects: 20
Study 1867967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7144761 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (20 mg/kg i.m. daily during artificial ventilation for up to 14 days)
Number of subjects: 78
Study 7144761 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin E treatment)
Number of subjects: 78
Study 7144761 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E group
Number of subjects: 78
Study 7144761 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 30938809 — intervention group
Group type: EXPERIMENTAL
Intervention: Lohmann Dual (LD) hens
Number of subjects: 2071
Study 30938809 — intervention group
Group type: EXPERIMENTAL
Intervention: Lohmann Dual (LD) eggs
Number of subjects: 2071
Study 30938809 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental crosses (DR, DS, KK hens mated with genetically different males)
Number of subjects: 2071
Study 30938809 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial insemination (AI) for NC and LD
Number of subjects: 2071
Study 30938809 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental meat-type males of NC and LD
Number of subjects: 2071
Study 30938809 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 2071
Study 28755266 — intervention group
Group type: EXPERIMENTAL
Intervention: Latiglutenase (900 mg, n=14)
Number of subjects: 398
Study 28755266 — intervention group
Group type: EXPERIMENTAL
Intervention: Latiglutenase
Number of subjects: 398
Study 28755266 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=54)
Number of subjects: 398
Study 25823136 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic treatment in addition to dexamethasone and methycobal; chiropractic included local muscle loosening, attacking point, bilateral pulling atlanto-axial joint, continuous treatment for 10 days.
Number of subjects: 90
Study 25823136 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone intravenous drip of 10 mg for 3 days, decreased to 5 mg for another 3 days; methycobal intravenous drip of 500 μg for 10 days.
Number of subjects: 90
Study 23317632 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 491
Study 23317632 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 491
Study 23317632 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjudicated bleeding assessments
Number of subjects: 491
Study 21671125 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze training (GAZE)
Number of subjects: 30
Study 21671125 — intervention group
Group type: COMPARATOR
Intervention: Movement training (MOVE)
Number of subjects: 30
Study 21671125 — intervention group
Group type: COMPARATOR
Intervention: Discovery learning/control (DISCOVERY)
Number of subjects: 30
Study 18929492 — intervention group
Group type: EXPERIMENTAL
Intervention: Single tube (32F chest tube)
Number of subjects: 100
Study 18929492 — intervention group
Group type: COMPARATOR
Intervention: Double tube (2 x 32F chest tubes)
Number of subjects: 100
Study 18085028 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine plus meperidine (Group MP): 5 ml fluid combination containing prilocaine (10 mg/ml) and meperidine (1 mg/kg) injected into nasal packs 15 minutes before removal
Number of subjects: 50
Study 18085028 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine (Group P): 5 ml of 1% prilocaine in saline injected into the pack 15 minutes before removal
Number of subjects: 50
Study 18085028 — intervention group
Group type: COMPARATOR
Intervention: Control: 5 ml saline injected into the contra-lateral nostril in both groups
Number of subjects: 50
Study 16279253 — intervention group
Group type: EXPERIMENTAL
Intervention: Different therapeutic strategies in HIV disease
Number of subjects: 0
Study 16279253 — intervention group
Group type: EXPERIMENTAL
Intervention: Data management processes
Number of subjects: 0
Study 16279253 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaboration of three governmental agencies
Number of subjects: 0
Study 11471515 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (Enbrel‐‐Wyeth)
Number of subjects: 0
Study 11471515 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (Remicade‐‐Schering Plough)
Number of subjects: 0
Study 11471515 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9792490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flight phobics; aHR when entering the plane: 17.5 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: COMPARATOR
Intervention: Non-anxious controls; aHR when entering the plane: 9.9 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flight phobics; aHR when leaving the hospital: 7.0 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: COMPARATOR
Intervention: Non-anxious controls; aHR when leaving the hospital: 8.6 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flight phobics; Raw HR when leaving the hospital: 118 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: COMPARATOR
Intervention: Non-anxious controls; Raw HR when leaving the hospital: 114 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flight phobics; Raw HR when entering the plane: 117 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: COMPARATOR
Intervention: Non-anxious controls; Raw HR when entering the plane: 110 bpm
Number of subjects: 43
Study 9792490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flight phobics; V during any condition: not higher than controls
Number of subjects: 43
Study 9792490 — intervention group
Group type: COMPARATOR
Intervention: Non-anxious controls; V during any condition: not higher than phobics
Number of subjects: 43
Study 7997841 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-smoking pregnant women
Number of subjects: 215
Study 7997841 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking pregnant women
Number of subjects: 215
Study 7997841 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy non-smoking females)
Number of subjects: 215
Study 7997841 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of non-smoking vs smoking pregnant women
Number of subjects: 215
Study 3057398 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral physostigmine
Number of subjects: 14
Study 3057398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31775515 — intervention group
Group type: EXPERIMENTAL
Intervention: RCL intervention
Number of subjects: 267
Study 30839301 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 minute static stretching
Number of subjects: 17
Study 30839301 — intervention group
Group type: COMPARATOR
Intervention: 5 minute control period
Number of subjects: 17
Study 28038810 — intervention group
Group type: EXPERIMENTAL
Intervention: LVAD pump speed set at 4
Number of subjects: 15
Study 28038810 — intervention group
Group type: COMPARATOR
Intervention: LVAD pump speed set at 2
Number of subjects: 15
Study 26154494 — intervention group
Group type: EXPERIMENTAL
Intervention: tPCS at 6-10 Hz
Number of subjects: 40
Study 26154494 — intervention group
Group type: EXPERIMENTAL
Intervention: tPCS at 11-15 Hz
Number of subjects: 40
Study 26154494 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study 23412704 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg single dose
Number of subjects: 276
Study 23412704 — intervention group
Group type: COMPARATOR
Intervention: Placebo 500 mg single dose
Number of subjects: 276
Study 21620555 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127)
Number of subjects: 213
Study 21620555 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n=86)
Number of subjects: 213
Study 21620555 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with bilateral hydatid
Number of subjects: 213
Study 21620555 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with bilateral hydatid
Number of subjects: 213
Study 21620555 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with fimbrial hydatid
Number of subjects: 213
Study 21620555 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with fimbrial hydatid
Number of subjects: 213
Study 21620555 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with single hydatid
Number of subjects: 213
Study 21620555 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with single hydatid
Number of subjects: 213
Study 21620555 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic excision of hydatid of Morgagni (n=127) with hydatid diameter of 1-2 cm
Number of subjects: 213
Study 21620555 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n=86) with hydatid diameter of 1-2 cm
Number of subjects: 213
Study 18461849 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary treatment at the Basel clinic
Number of subjects: 0
Study 18461849 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal sample)
Number of subjects: 0
Study 18461849 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperament ratings by mothers of treated children
Number of subjects: 0
Study 17078217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary injection of bone marrow autologous mononuclear cells (BMAMC) after stenting the coronary artery, performed on AMI day 7-21.
Number of subjects: 26
Study 17078217 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BMAMC treatment).
Number of subjects: 26
Study 12616005 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 20
Study 12616005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12616005 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary caffeine consumption
Number of subjects: 20
Study 10878144 — intervention group
Group type: EXPERIMENTAL
Intervention: Gun safety counseling intervention (60-second message about gun safety)
Number of subjects: 1295
Study 10878144 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 1295
Study 8883532 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol at 270 mg I/ml
Number of subjects: 150
Study 8883532 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol at 320 mg I/ml
Number of subjects: 150
Study 8883532 — intervention group
Group type: COMPARATOR
Intervention: Iohexol at 300 mg I/ml
Number of subjects: 150
Study 1555904 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 27
Study 4003142 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.32 mg/kg of 95% USP alcohol
Number of subjects: 44
Study 4003142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 31984648 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 45
Study 31984648 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (Control)
Number of subjects: 45
Study 30553555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose (150 mg) pregabalin
Number of subjects: 90
Study 30553555 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (300 mg) pregabalin
Number of subjects: 90
Study 30553555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 90
Study 28113680 — intervention group
Group type: EXPERIMENTAL
Intervention: Greedy deterministic approach
Number of subjects: 0
Study 28113680 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandit-based algorithm
Number of subjects: 0
Study 28113680 — intervention group
Group type: COMPARATOR
Intervention: Exact versions of OMP or FW algorithms
Number of subjects: 0
Study 27619564 — intervention group
Group type: EXPERIMENTAL
Intervention: EQClinic training during weeks 1-5 (group A)
Number of subjects: 268
Study 27619564 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleconsultation between the two face-to-face consultations (group B)
Number of subjects: 268
Study 27619564 — intervention group
Group type: EXPERIMENTAL
Intervention: EQClinic training before the first face-to-face consultation (group A)
Number of subjects: 268
Study 27619564 — intervention group
Group type: COMPARATOR
Intervention: Course curriculum components only (group B)
Number of subjects: 268
Study 24732447 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptococcus pneumoniae meningitis
Number of subjects: 206
Study 24732447 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemophilus influenzae meningitis
Number of subjects: 206
Study 24732447 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of pneumococcal vs H.influenzae meningitis
Number of subjects: 206
Study 24732447 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who succumbed within 8 hours
Number of subjects: 206
Study 22496401 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-invitation group (started receiving food supplements at 9 weeks gestation)
Number of subjects: 180